| 1 | [SID103189394] | Active | Kd | 25 | Ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 2 [AID30389, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103189394 | | CID | 31268 | | Outcome | Active | | Kd | 25 [uM] | | BioAssay | Ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 2 | | AID | 30389 | | BioAssay type | Literature | | Target | | | PubMed | 4032427 | | Data Table |  |
|
| 2 | [SID103189394] | Unspecified | Ki | 38000 | Inhibition of human PAT1-mediated L-[3H]proline uptake in human Caco2 cells after 10 mins by liquid scintillation counting [AID630741, Type: Literature] | Proton-coupled amino acid transporter 1 [gi:51316800] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103189394 | | CID | 31268 | | Outcome | Unspecified | | Ki | 38000 [uM] | | BioAssay | Inhibition of human PAT1-mediated L-[3H]proline uptake in human Caco2 cells after 10 mins by liquid scintillation counting | | AID | 630741 | | BioAssay type | Literature | | Target | Proton-coupled amino acid transporter 1 [gi:51316800] | | PubMed | 21955456 | | Data Table |  |
|
| 3 | [SID103189394] | Unspecified | | | Maximum percent of enhancement of binding. [AID30377, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103189394 | | CID | 31268 | | Outcome | Unspecified | | BioAssay | Maximum percent of enhancement of binding. | | AID | 30377 | | BioAssay type | Literature | | Target | | | PubMed | 4032427 | | Data Table |  |
|
| 4 | [SID103189394] | Unspecified | | | Compounds was evaluate for their ability to enhance (+/-)-[3H]nicotine binding at a dose range 10 E -10 - 10 E -6 M was reported [AID30521, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103189394 | | CID | 31268 | | Outcome | Unspecified | | BioAssay | Compounds was evaluate for their ability to enhance (+/-)-[3H]nicotine binding at a dose range 10 E -10 - 10 E -6 M was reported | | AID | 30521 | | BioAssay type | Literature | | Target | | | PubMed | 4032427 | | Data Table |  |
|
| 5 | [SID103189394] | Unspecified | | | Maximum percent of inhibition of binding was determined [AID30378, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103189394 | | CID | 31268 | | Outcome | Unspecified | | BioAssay | Maximum percent of inhibition of binding was determined | | AID | 30378 | | BioAssay type | Literature | | Target | | | PubMed | 4032427 | | Data Table |  |
|
| 6 | [SID103189394] | Unspecified | | | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-10-10e-6 [AID30382, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103189394 | | CID | 31268 | | Outcome | Unspecified | | BioAssay | Compound was evaluated for ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 1; 10e-10-10e-6 | | AID | 30382 | | BioAssay type | Literature | | Target | | | PubMed | 4032427 | | Data Table |  |
|
| 7 | [SID109780] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P1534 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID316, Type: other] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 109780 | | CID | 31268 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P1534 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 316 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID109780] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P1534 Leukemia (intraperitoneal) in DBA/2 mice [AID314, Type: other] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 109780 | | CID | 31268 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P1534 Leukemia (intraperitoneal) in DBA/2 mice | | AID | 314 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID109780] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice [AID270, Type: other] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 109780 | | CID | 31268 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice | | AID | 270 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID109780] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice [AID248, Type: other] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 109780 | | CID | 31268 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice | | AID | 248 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID103189394] | Inactive | | | Superoxide release activity in potassium phosphate buffer at pH 7.4 and 25 uM after 30 mins by luminol-based colorimetric assay [AID661629, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103189394 | | CID | 31268 | | Outcome | Inactive | | BioAssay | Superoxide release activity in potassium phosphate buffer at pH 7.4 and 25 uM after 30 mins by luminol-based colorimetric assay | | AID | 661629 | | BioAssay type | Literature | | Target | | | PubMed | 22542016 | | Data Table |  |
|
| 12 | [SID103189394] | Inactive | | | Hydrogen peroxide release activity in potassium phosphate buffer at pH 7.4 after 60 mins by xylene-orange based colorimetric assay [AID661627, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103189394 | | CID | 31268 | | Outcome | Inactive | | BioAssay | Hydrogen peroxide release activity in potassium phosphate buffer at pH 7.4 after 60 mins by xylene-orange based colorimetric assay | | AID | 661627 | | BioAssay type | Literature | | Target | | | PubMed | 22542016 | | Data Table |  |
|